Search results
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 23 hours agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...
What's Going With BioNTech Stock On Monday?
Benzinga· 18 hours agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
Q1 2024 BioNTech SE Earnings Call Transcript
Guru Focus· 22 hours agoThank you for joining BioNTech's First Quarter 2024 Earnings Call. As a reminder, the slides we will be using on this call and the corresponding press release published this ...
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 24 hours agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...
BioNTech says 90% of 2024 revenues will accrue at end of year
WHTC 1450 Holland· 23 hours agoFRANKFURT (Reuters) - Germany's BioNTech, whose COVID-19 vaccine in partnership with Pfizer was...
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters· 23 hours ago, opens new tab was widely used during the pandemic, said on Monday that almost all of its expected...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 23 hours agoGerman Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a loss in its first quarter, compared to prior year's profit with sharply ...
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 7 days agoOn BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the...
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 1 day agoAmerican depositary receipts (ADRs) of BioNTech (BNTX) were down less than 1% in intraday trading...
BioNTech Swings to Net Loss on Lower Covid Vaccine Sales
Market Watch· 23 hours agoBioNTech swung to a net loss in the first quarter, when revenue plummeted after a sharp decline in its Covid-19 vaccine sales. The German biotechnology company, listed on ...